公開日期 | 標題 | 作者 | 來源出版物 | WOS | 全文 |
2010 | Immunoglobulin G Fc Receptor Fc gamma RIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma | Wen-Kai Weng ; Negrin, R. S.; Lavori, P.; Horning, S. J. | Journal of Clinical Oncology | | |
2004 | Immunoglobulin G Fc receptor polymorphisms and clinical course in follicular lymphoma patients | Wen-Kai Weng ; Rosenberg, A.; Levy, R. | Blood | | |
2009 | Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma | Wen-Kai Weng ; Levy, R. | Leukemia & Lymphoma | | |
2011 | Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results | Brody, J. D.; Czerwinski, D. K.; Carlton, V.; Moorhead, M.; Zheng, J. B. A.; Klinger, M.; Faham, M.; Advani, R.; Kohrt, H. E.; Alizadeh, A. A.; Negrin, R. S.; Weng, WK ; Sheehan, K.; Levy, R. | Blood | 0 | |
2018 | Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation | Muffly, L.; Sheehan, K.; Armstrong, R.; Jensen, K.; Tate, K.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood Advances | | |
2023 | Investigation into increasing wave energy density by a crescent shoal | Bo-Jun Wang; Chi-Yu Li ; Ruey Syan Shih ; Wen-Kai Weng | | | |
2020 | Investigation of Ocean-Wave-Focusing Characteristics Induced by a Submerged Crescent-Shaped Plate for Long-Crested Waves | Li, Chi-Yu ; Shih, Ruey-Syan ; Weng, Wen-Kai | WATER-SUI | 2 | |
2019 | Investigation on the Wave Attenuation and Reflection Induced by a Submerged Barrier in Presence of Small Forward and Reversed Currents | Ruey-Syan Shih ; Wen-Kai Weng ; Chi-Yu Li ; Chia-Ying Wu; Ying-Chi Wang | The 29th International Ocean and Polar Engineering Conference | | |
2019 | Investigation on the wave attenuation physical quantities of stepped embankments considering forward and reversed flow field | Ruey-Syan Shih ; Wen-Kai Weng ; Chi-Yu Li ; Chia-Ying Wu; Ying-Chi Wang | | | |
2006 | The long term clinical outcome of B cell lymphoma patients treated with anti-idiotype monoclonal antibody correlated with the isotype of the therapeutic antibody | Wen-Kai Weng ; Czerwinski, D.; Levy, R. | Blood | | |
2016 | Long-Term Outcomes of AML Patients Using Total Lymphoid Irradiation with Anti-Thymocyte Globulin | Nakasone, H.; Miklos, D. B.; Meyer, E.; Rezvani, A.; Muffly, L.; Wen-Kai Weng ; Arai, S.; Johnston, L.; Laport, G. G.; Shizuru, J. A.; Negrin, R.; Strober, S.; Lowsky, R. | Biology of Blood and Marrow Transplantation | | |
2016 | Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma | Neppalli, A. K.; Shizuru, J.; Johnston, L. J.; Muffly, L. S.; Wen-Kai Weng ; Negrin, R.; Meyer, E.; Laport, G.; Lowsky, R.; Arai, S.; Miklos, D. B.; Rezvani, A. R. | Journal of Clinical Oncology | | |
2020 | Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program Study | Prockop, S. E.; Reshef, R.; Tsai, D. E.; Bunin, N.; Abu-Arja, R.; Mahadeo, K. M.; Wen-Kai Weng ; van Besien, K.; Loeb, D.; Nasta, S. D.; Nemecek, E. R.; Hiremath, M.; Yue, S.; Sun, Y.; Navarro, W. H.; Nikiforow, S. | Biology of Blood and Marrow Transplantation | | |
2013 | Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Desmarais, C.; Hoppe, R.; Kim, Y. H. | Science Translational Medicine | | |
2005 | A non-internalizing anti-CD40 antibody, CHIR-12.12, blocks CD40L-induced cytokine production and mediates greater ADCC than rituximab in primary CLL cells | Tong, X.; Aukerman, S. L.; Lin, K.; Aziz, N.; Goldbeck, C.; Georgakis, G. V.; Younes, G.; Wen-Kai Weng ; O'Brien, S.; Wierda, W.; Jallal, B.; Luqman, M. | Blood | | |
2014 | Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Benjamin, J. E.; Negrin, R. S.; Reddy, S.; Million, L.; Hoppe, R. T.; Kim, Y. H. | Blood | | |
2012 | Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms | Benjamin, J.; Chhabra, S.; Kohrt, H. E.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Blood | | |
2020 | Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma | Wen-Kai Weng ; Arai, S.; Rezvani, A.; Johnston, L.; Lowsky, R.; Miklos, D.; Shizuru, J.; Muffly, L.; Meyer, E.; Negrin, R. S.; Wang, E.; Almazan, T.; Million, L.; Khodadoust, M.; Li, S. F.; Hoppe, R. T.; Kim, Y. H. | Blood Advances | | |
2018 | Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Elder, L. V.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood | | |
2019 | Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort | Spinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R. | Blood Advances | | |